Hydrochloric Acid

Hydrochloric Acid

SCHEMBL450435

CCc1ccc2c(c1C1=CC=CC1)C([Zr+2]=C(c1ccccc1)c1ccccc1)c1cccc(CC)c1-2.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.33
HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10308872-B2 Composite marking based on chiral liquid crystal precursors and modifying resins SICPA HOLDING SA (CH) 2019-06-04 US disclosed
EP-2714412-B1 SUBSTRATE WITH A MODIFIED LIQUID CRYSTAL POLYMER MARKING SICPA HOLDING SA (CH) 2019-03-13 EP disclosed
EP-3126149-B1 MARKING COMPRISING A CHIRAL LIQUID CRYSTAL POLYMER AND A LUMINESCENT SUBSTANCE SICPA HOLDING SA (CH) 2018-12-26 EP disclosed
EP-2414986-B1 IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS SICPA HOLDING SA (CH) 2017-06-14 EP disclosed
US-20160272890-A1 COMPOSITE MARKING BASED ON CHIRAL LIQUID CRYSTAL PRECURSORS AND MODIFYING RESINS SICPA HOLDING SA (CH) 2016-09-22 US disclosed
EP-1473323-B1 Polyethylene composition and process for producing same TOSOH CORP (JP) 2016-04-27 EP disclosed
US-9200204-B2 Identification and authentication using polymeric liquid crystal material markings SICPA HOLDING SA (CH) 2015-12-01 US disclosed
US-8734678-B2 Identification and authentication using polymeric liquid crystal material markings SICPA HOLDING SA (CH) 2014-05-27 US disclosed
US-20130069003-A1 IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS SICPA HOLDING SA (CH) 2013-03-21 US disclosed
US-20120061470-A1 IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS SICPA HOLDING SA (CH) 2012-03-15 US disclosed
EP-1473323-A1 Polyethylene composition and process for producing same Tosoh Corporation (JP) 2004-11-03 EP disclosed
US-20040214953-A1 Polyethylene composition and process for producing same TOSOH CORPORATION 2004-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120061470-A1 IDENTIFICATION AND AUTHENTICATION USING POLYMERIC LIQUID CRYSTAL MATERIAL MARKINGS INCENP, MKI67, ATG4B HTR7 1708/4885HTR2B 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.